05 January 2014
To Silvia Del Castillo Arrojo of the Fuenlabrada University Hospital for the project: How implantable defibrillators are currently managed in Spain in terminally ill patients and in end-of-life care. Are we considering deactivation?
Implantable cardioverter defibrillators (ICDs) have proven to be useful in preventing sudden death originating from cardiac arrhythmia. However the use of ICDs has given rise to controversy in recent years. The aims of this study are to discover the current situation at centers which implant and monitor the defibrillators in Spain in terminally ill patients or with a poor quality of life. The research focuses on finding out whether an established protocol exists for ICD management in terminal cases, and whether patients are informed of the possibility of deactivating the electrical shock therapies, and who decides this, among other issues.